Nicardipine

Generic Name
Nicardipine
Brand Names
Cardene
Drug Type
Small Molecule
Chemical Formula
C26H29N3O6
CAS Number
55985-32-5
Unique Ingredient Identifier
CZ5312222S
Background

A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem]

Indication

Used for the management of patients with chronic stable angina and for the treatment of hypertension.

Associated Conditions
Chronic Stable Angina Pectoris, Hypertension, Migraine, Blood pressure >185/110 mm Hg arterial hypertension
Associated Therapies
-

Hypotensive Anesthesia for Orthognathic Surgery

First Posted Date
2023-10-23
Last Posted Date
2024-12-05
Lead Sponsor
Boston Medical Center
Target Recruit Count
90
Registration Number
NCT06093893
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

Effects of Subcutaneously Infiltrated Nicardipine on the Success Rate of Radial Artety Cannulation

First Posted Date
2023-06-27
Last Posted Date
2023-06-27
Lead Sponsor
Mahidol University
Target Recruit Count
190
Registration Number
NCT05920538
Locations
🇹🇭

Anesthesiology Department, Bangkok, Thailand

Dilution of Verapamil During Intraarterial Administration

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-11-23
Last Posted Date
2024-11-27
Lead Sponsor
University of Illinois at Chicago
Target Recruit Count
55
Registration Number
NCT05625503
Locations
🇺🇸

University of Illinois Hospital, Chicago, Illinois, United States

Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery

First Posted Date
2022-10-19
Last Posted Date
2022-10-19
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
64
Registration Number
NCT05586347
Locations
🇨🇳

Hongwei Shi, Nanjing, Jiangsu, China

Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention

Phase 3
Completed
Conditions
Interventions
First Posted Date
2020-09-04
Last Posted Date
2022-02-08
Lead Sponsor
Pr. Semir Nouira
Target Recruit Count
1500
Registration Number
NCT04538534
Locations
🇹🇳

CHU Fattouma Bourguiba, Monastir, Tunisia

A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

First Posted Date
2020-02-13
Last Posted Date
2023-07-12
Lead Sponsor
BIT Pharma GmbH
Target Recruit Count
41
Registration Number
NCT04269408
Locations
🇦🇹

Kepler Universitätsklinikum, Universitätsklinik für Neurochirurgie, Linz, Austria

🇦🇹

Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie, Innsbruck, Austria

🇩🇪

Universitätsklinikum Göttingen, Neurochirurgische Klinik, Göttingen, Germany

and more 3 locations

Blood Pressure After Endovascular Stroke Therapy-II

First Posted Date
2019-10-04
Last Posted Date
2023-10-12
Lead Sponsor
University of Cincinnati
Target Recruit Count
120
Registration Number
NCT04116112
Locations
🇺🇸

Hartford Healthcare, Hartford, Connecticut, United States

🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-04-13
Last Posted Date
2020-08-26
Lead Sponsor
Chinese PLA General Hospital
Target Recruit Count
59
Registration Number
NCT03497351
Locations
🇨🇳

Chinese PLA General Hospital, Beijing, Haidian, China

Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine

Early Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2017-06-12
Last Posted Date
2024-04-26
Lead Sponsor
Thomas Jefferson University
Registration Number
NCT03184155
Locations
🇺🇸

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2015-09-23
Last Posted Date
2020-08-25
Lead Sponsor
University Hospital, Strasbourg, France
Target Recruit Count
14
Registration Number
NCT02558023
Locations
🇫🇷

Service d'Anesthésie - CMCO, Schiltigheim, France

🇫🇷

Service d'Anesthésie et de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

© Copyright 2024. All Rights Reserved by MedPath